Nose Diseases D009668

Diseases [C] » Respiratory Tract Diseases [C08] » Nose Diseases

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Nose Diseases

Description

Disorders of the nose, general or unspecified.   MeSH

Hierarchy View

Subtype Terms (11)

Choanal Atresia
1 approved drug

Epistaxis
19 drugs (16 approved, 3 experimental)

Granuloma, Lethal Midline
 

Nasal Obstruction
36 drugs (30 approved, 6 experimental)

Nasal Polyps
35 drugs (27 approved, 8 experimental)

Nasal Septal Perforation
9 drugs (6 approved, 3 experimental)

Nose Deformities, Acquired
3 approved drugs

Nose Neoplasms
5 approved drugs

Paranasal Sinus Diseases
8 drugs (7 approved, 1 experimental)

Rhinitis
61 drugs (38 approved, 23 experimental)

Rhinoscleroma
3 approved drugs


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (2)

Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.